What happened Shares of the medical device company Nevro (NYSE: NVRO) were down by an unsightly 18.9% on exceptionally heavy volume at 10:57 a.m. The big loss came after the company announced that Kevin Thornal will take the reins as CEO and president following the upcoming retirement of current CEO/president D. Keith Grossman on April 24, 2023. The bottom line is that rising interest rates and stubborn levels of inflation have pushed investors into safe haven assets like dividend stocks over the past year and a half.